ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

NIH review finds 44 scientists violated ethics rules on industry consulting, House committee chairman says.

July 15, 2005

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome

February 24, 2012

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

RFA: Clinical Correlative Studies In Solid Tumors

April 3, 1992

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014